IQCF6
gene geneOn this page
Summary
IQCF6 (IQ motif containing F6, HGNC:35158) is a protein-coding gene on chromosome 3p21.2, encoding IQ domain-containing protein F6 (A8MYZ5).
Predicted to enable calmodulin binding activity.
Source: NCBI Gene 440956 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 20 total
- MANE Select transcript:
NM_001368369
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35158 |
| Approved symbol | IQCF6 |
| Name | IQ motif containing F6 |
| Location | 3p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214686 |
| Ensembl biotype | protein_coding |
| Entrez | 440956 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000398780, ENST00000647442, ENST00000667863, ENST00000668964
RefSeq mRNA: 3 — MANE Select: NM_001368369
NM_001143833, NM_001368368, NM_001368369
CCDS: CCDS54590, CCDS93280, CCDS93281
Canonical transcript exons
ENST00000667863 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003814583 | 51778563 | 51778991 |
| ENSE00003863118 | 51779153 | 51779237 |
Expression profiles
Bgee: expression breadth broad, 34 present calls, max score 97.24.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0040 / max 4.0598, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42367 | 0.0040 | 3 |
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.24 | gold quality |
| sperm | CL:0000019 | 93.27 | gold quality |
| left testis | UBERON:0004533 | 81.65 | gold quality |
| right testis | UBERON:0004534 | 81.02 | gold quality |
| testis | UBERON:0000473 | 78.86 | gold quality |
| buccal mucosa cell | CL:0002336 | 65.39 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 64.24 | gold quality |
| adult organism | UBERON:0007023 | 60.89 | silver quality |
| myocardium | UBERON:0002349 | 59.91 | gold quality |
| pericardium | UBERON:0002407 | 59.64 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 58.21 | gold quality |
| parotid gland | UBERON:0001831 | 57.70 | gold quality |
| medial globus pallidus | UBERON:0002477 | 57.29 | gold quality |
| vena cava | UBERON:0004087 | 56.54 | gold quality |
| endothelial cell | CL:0000115 | 55.02 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 54.99 | gold quality |
| cartilage tissue | UBERON:0002418 | 54.45 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 54.40 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 54.20 | gold quality |
| decidua | UBERON:0002450 | 54.00 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.78 | gold quality |
| globus pallidus | UBERON:0001875 | 53.62 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| colonic mucosa | UBERON:0000317 | 53.12 | gold quality |
| deltoid | UBERON:0001476 | 52.85 | gold quality |
| pancreatic ductal cell | CL:0002079 | 52.79 | silver quality |
| quadriceps femoris | UBERON:0001377 | 52.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.31 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Iqcf6 | ENSMUSG00000091129 |
| rattus_norvegicus | Iqcf6 | ENSRNOG00000042065 |
Paralogs (4): IQCF1 (ENSG00000173389), IQCF2 (ENSG00000184345), IQCF5 (ENSG00000214681), IQCF3 (ENSG00000229972)
Protein
Protein identifiers
IQ domain-containing protein F6 — A8MYZ5 (reviewed: A8MYZ5)
All UniProt accessions (4): A8MYZ5, A0A2R8Y4M9, A0A590UIX9, A0A590UJ54
RefSeq proteins (3): NP_001137305, NP_001355297, NP_001355298* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR039887 | IQCF | Family |
Pfam: PF00612
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MYZ5-F1 | 93.31 | 0.73 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, chr3p21, GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN, GOMF_CALMODULIN_BINDING
GO Biological Process (0):
GO Molecular Function (2): calmodulin binding (GO:0005516), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
198 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IQCF6 | FAM24A | A6NFZ4 | 612 |
| IQCF6 | PRR30 | Q53SZ7 | 506 |
| IQCF6 | POC1A | Q8NBT0 | 494 |
| IQCF6 | CPXCR1 | Q8N123 | 490 |
| IQCF6 | TMED6 | Q8WW62 | 481 |
| IQCF6 | CSTL1 | Q9H114 | 471 |
| IQCF6 | RNF148 | Q8N7C7 | 453 |
| IQCF6 | CFAP53 | Q96M91 | 449 |
| IQCF6 | XTBD1 | Q96HQ2 | 447 |
| IQCF6 | NEMP1 | O14524 | 428 |
| IQCF6 | PDCD2L | Q9BRP1 | 400 |
| IQCF6 | C9JR48 | C9JR48 | 393 |
| IQCF6 | COG8 | Q96MW5 | 380 |
| IQCF6 | ENTR1 | Q96C92 | 370 |
| IQCF6 | MIGA1 | Q8NAN2 | 370 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A1A5Q7, A4D126, A4II32, A6NCI4, A8K8P3, A8MTL0, A8MYZ5, A9CB34, E0CYC6, F1QWK4, O14772, O15554, O89109, P0C7M6, P0C8N6, Q05AA6, Q08CB3, Q13474, Q1HAQ0, Q1LWG4, Q2M2U5, Q32KU4, Q3SYS7, Q3TFD2, Q3UVV9, Q4AC99, Q5I0I4, Q5R796, Q5RFS1, Q8BHD4, Q8BP00, Q8BPW0, Q8CB65, Q8CHT6, Q8IXL9, Q8K2I9, Q8N0W5, Q8N6M8, Q8NEA4, Q8NF37
Diamond homologs: A8MTL0, A8MYZ5, P0C7M6, Q2M2U5, Q32KU4, Q3SYS7, Q6AXX0, Q8IXL9, Q8N6M8, Q9D498, Q9D9K8, Q9DAL7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
20 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
90 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:51778992:C:CC | acceptor_gain | 0.9800 |
| 3:51778988:CTAA:C | acceptor_gain | 0.9700 |
| 3:51778989:TAA:T | acceptor_gain | 0.9600 |
| 3:51778992:CT:C | acceptor_loss | 0.9500 |
| 3:51778996:T:TC | acceptor_gain | 0.9300 |
| 3:51779170:TACC:T | donor_loss | 0.9300 |
| 3:51779172:C:CG | donor_loss | 0.9300 |
| 3:51778990:AA:A | acceptor_gain | 0.8900 |
| 3:51778996:T:C | acceptor_gain | 0.8800 |
| 3:51779169:TTA:T | donor_gain | 0.8400 |
| 3:51779170:TA:T | donor_gain | 0.8400 |
| 3:51779168:ATTAC:A | donor_gain | 0.8300 |
| 3:51779171:A:AT | donor_gain | 0.8300 |
| 3:51779172:C:G | donor_gain | 0.8300 |
| 3:51779167:CATTA:C | donor_gain | 0.8200 |
| 3:51779173:C:G | donor_gain | 0.8000 |
| 3:51778987:TCTA:T | acceptor_gain | 0.7800 |
| 3:51779107:T:TA | donor_gain | 0.7700 |
| 3:51778995:A:AC | acceptor_gain | 0.7600 |
| 3:51779153:A:C | donor_gain | 0.7300 |
| 3:51778995:A:C | acceptor_gain | 0.7200 |
| 3:51779174:T:G | donor_gain | 0.7000 |
| 3:51778990:AACT:A | acceptor_gain | 0.6900 |
| 3:51778987:TCTAA:T | acceptor_gain | 0.6800 |
| 3:51778988:CTAAC:C | acceptor_gain | 0.6800 |
| 3:51778989:TAACT:T | acceptor_gain | 0.6800 |
| 3:51778991:ACTGA:A | acceptor_gain | 0.6800 |
| 3:51779151:A:AC | donor_gain | 0.6700 |
| 3:51779152:C:CC | donor_gain | 0.6700 |
| 3:51778992:C:A | acceptor_gain | 0.6600 |
AlphaMissense
937 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:51778761:G:C | F62L | 0.909 |
| 3:51778761:G:T | F62L | 0.909 |
| 3:51778763:A:G | F62L | 0.909 |
| 3:51778636:A:G | I104T | 0.859 |
| 3:51778782:C:A | M55I | 0.838 |
| 3:51778782:C:G | M55I | 0.838 |
| 3:51778782:C:T | M55I | 0.838 |
| 3:51778889:A:G | W20R | 0.825 |
| 3:51778889:A:T | W20R | 0.825 |
| 3:51778797:C:A | Q50H | 0.818 |
| 3:51778797:C:G | Q50H | 0.818 |
| 3:51778762:A:G | F62S | 0.811 |
| 3:51778732:A:T | I72N | 0.806 |
| 3:51778786:C:G | R54P | 0.793 |
| 3:51778732:A:G | I72T | 0.791 |
| 3:51778900:A:G | I16T | 0.785 |
| 3:51778887:C:A | W20C | 0.781 |
| 3:51778887:C:G | W20C | 0.781 |
| 3:51778741:G:T | A69D | 0.775 |
| 3:51778900:A:T | I16N | 0.775 |
| 3:51778732:A:C | I72S | 0.770 |
| 3:51778796:C:G | A51P | 0.763 |
| 3:51778636:A:C | I104S | 0.757 |
| 3:51778900:A:C | I16S | 0.722 |
| 3:51778728:C:A | Q73H | 0.721 |
| 3:51778728:C:G | Q73H | 0.721 |
| 3:51778896:C:A | Q17H | 0.716 |
| 3:51778896:C:G | Q17H | 0.716 |
| 3:51778721:A:G | W76R | 0.709 |
| 3:51778721:A:T | W76R | 0.709 |
dbSNP variants (sampled 300 via entrez): RS1001241308 (3:51780032 G>A,T), RS1001460599 (3:51780154 C>T), RS1002468022 (3:51779042 C>A,T), RS1002597987 (3:51778440 G>A,C), RS1003603513 (3:51779827 CT>C,CTT,CTTT), RS1003657258 (3:51780217 C>T), RS1003903787 (3:51779337 G>A), RS1004879865 (3:51780743 T>G), RS1005309494 (3:51779439 G>A), RS1005383013 (3:51779714 T>C), RS1005475034 (3:51780350 TC>T), RS1006428912 (3:51778536 A>C,G), RS1006719545 (3:51781078 G>A), RS1007000785 (3:51780622 A>C,G,T), RS1007931047 (3:51778121 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.